BIOA INVESTOR DEADLINE: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
CASE ALLEGATIONS: BioAge Labs is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. In the IPO, BioAge Labs sold 12.65 million shares at ...
BreakPoint Labs Awarded SeaPort Next Generation (NxG) Prime Contract
BreakPoint Labs, LLC ("BreakPoint Labs"), a technically proficient, mission-focused cybersecurity service provider, is ...
Nadcab Labs Sets New Standard in Blockchain Innovation with Advanced Smart Contract Services
A new benchmark in blockchain innovation is being set with advanced smart contract services. Offering expert auditing and ...
BioAge Labs, Inc. Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the BIOA Class Action
SAN DIEGO, CA / ACCESSWIRE / January 15, 2025 / Robbins LLP reminds investors that a class action was filed on behalf of all ...